Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunxia Su

Showing results (191-200 of 223) with videos related to

Pageof 23
Sort By:
International Journal of Cancer|November 3, 2018
EGFR-TKIs plus local therapy demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with oligometastatic or oligoprogressive liver metastasesTao Jiang, Qian Chu, Huijuan Wang, et al.
Translational Lung Cancer Research|April 11, 2022
Three-dimensionally printed navigational template: a promising guiding approach for lung biopsyHaoran E, Jiafei Chen, Weiyan Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2020
Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung AdenocarcinomaTao Jiang, Zhaoyuan Fang, Shijie Tang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancerXiaozhen Liu, Tao Jiang, Wei Li, et al.
Clinical Lung Cancer|May 28, 2017
Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter StudyTao Jiang, Ruirui Cheng, Guowei Zhang, et al.
Cancer Immunology Research|February 14, 2019
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung CancerSha Zhao, Shengxiang Ren, Tao Jiang, et al.
Translational Lung Cancer Research|September 21, 2020
Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitorsSangtian Liu, Fei Zhou, Zhiyu Liu, et al.
International Journal of Cancer|April 29, 2014
Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFRShengxiang Ren, Chunxia Su, Zhaoye Wang, et al.
Translational Lung Cancer Research|September 21, 2020
Impact of ALK variants on brain metastasis and treatment response in advanced NSCLC patients with oncogenic ALK fusionMeng Qiao, Chao Zhao, Qian Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphismSangtian Liu, Yayi He, Tao Jiang, et al.
Pageof 23

Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
International Journal of Cancer|November 3, 2018
EGFR-TKIs plus local therapy demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with oligometastatic or oligoprogressive liver metastasesTao Jiang, Qian Chu, Huijuan Wang, et al.
Translational Lung Cancer Research|April 11, 2022
Three-dimensionally printed navigational template: a promising guiding approach for lung biopsyHaoran E, Jiafei Chen, Weiyan Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2020
Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung AdenocarcinomaTao Jiang, Zhaoyuan Fang, Shijie Tang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancerXiaozhen Liu, Tao Jiang, Wei Li, et al.
Clinical Lung Cancer|May 28, 2017
Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter StudyTao Jiang, Ruirui Cheng, Guowei Zhang, et al.
Cancer Immunology Research|February 14, 2019
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung CancerSha Zhao, Shengxiang Ren, Tao Jiang, et al.
Translational Lung Cancer Research|September 21, 2020
Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitorsSangtian Liu, Fei Zhou, Zhiyu Liu, et al.
International Journal of Cancer|April 29, 2014
Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFRShengxiang Ren, Chunxia Su, Zhaoye Wang, et al.
Translational Lung Cancer Research|September 21, 2020
Impact of ALK variants on brain metastasis and treatment response in advanced NSCLC patients with oncogenic ALK fusionMeng Qiao, Chao Zhao, Qian Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphismSangtian Liu, Yayi He, Tao Jiang, et al.
Pageof 23